Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Fig. 4

Landmark analysis of 90-day ICU survival according to CAPA diagnosis. Day 14 after ICU admission was chosen as landmark date, as most CAPA diagnosis occurred before this time point. 90-day overall survival estimates were 52.9% in patients without CAPA and 14.6% in patients with CAPA (p = 0.026). Abbreviation: CAPA COVID-19-associated pulmonary aspergillosis; ICU intensive care unit

Back to article page

Critical Care

ISSN: 1364-8535